获批上市-话题@MedSci

#获批上市#

99篇内容 | 2622人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1632589, encodeId=3ce3163258967, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=重量减轻10倍！全球**便携式MRI床头扫描仪获批上市, objectType=article, longId=188030, objectId=68b618803061, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68b618803061, replyNumber=0, likeNumber=72, createdTime=2020-09-10, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68b618803061, moduleTitle=重量减轻10倍！全球**便携式MRI床头扫描仪获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68b618803061)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632590, encodeId=cf2a1632590b4, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=潜在治疗新冠肺炎药物获批上市，湖北以外新增确诊病例13连降, objectType=article, longId=188324, objectId=0c39188324e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c39188324e4, replyNumber=0, likeNumber=57, createdTime=2020-06-09, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c39188324e4, moduleTitle=潜在治疗新冠肺炎药物获批上市，湖北以外新增确诊病例13连降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c39188324e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632587, encodeId=320b163258e73, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=全球第二款！中国自主研发13价肺炎结合疫苗获批上市, objectType=article, longId=185541, objectId=cfc7185541fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfc7185541fc, replyNumber=0, likeNumber=89, createdTime=2020-04-14, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfc7185541fc, moduleTitle=全球第二款！中国自主研发13价肺炎结合疫苗获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfc7185541fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632586, encodeId=4bc91632586c2, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=国产重组人乳头瘤病毒疫苗“馨可宁”获批上市, objectType=article, longId=185540, objectId=3465185540f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3465185540f6, replyNumber=0, likeNumber=58, createdTime=2020-06-20, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3465185540f6, moduleTitle=国产重组人乳头瘤病毒疫苗“馨可宁”获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3465185540f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632585, encodeId=d32216325856e, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=百济神州抗PD-1抗体药物百泽安®（替雷利珠单抗注射液）终于获批上市了, objectType=article, longId=185383, objectId=415318538314, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=415318538314, replyNumber=0, likeNumber=66, createdTime=2020-02-03, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=415318538314, moduleTitle=百济神州抗PD-1抗体药物百泽安®（替雷利珠单抗注射液）终于获批上市了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=415318538314)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632575, encodeId=cf7316325e5e1, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症, objectType=article, longId=165885, objectId=92ae165885e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92ae165885e9, replyNumber=0, likeNumber=113, createdTime=2019-08-21, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92ae165885e9, moduleTitle=罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92ae165885e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632582, encodeId=f4641632582b0, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=中国首台自主知识产权碳离子治疗系统获批上市, objectType=article, longId=180405, objectId=6a041804055e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a041804055e, replyNumber=0, likeNumber=81, createdTime=2020-08-30, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a041804055e, moduleTitle=中国首台自主知识产权碳离子治疗系统获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a041804055e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632583, encodeId=624e1632583fb, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=全球用于稳定期慢阻肺治疗的一天一次三联吸入制剂“全再乐”在中国获批上市, objectType=article, longId=182659, objectId=e734182659b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e734182659b9, replyNumber=0, likeNumber=67, createdTime=2020-05-24, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e734182659b9, moduleTitle=全球用于稳定期慢阻肺治疗的一天一次三联吸入制剂“全再乐”在中国获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e734182659b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632572, encodeId=246916325e222, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=绿叶制药Rykindo有望成为我国在美获批上市的创新药, objectType=article, longId=163242, objectId=b93616324258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b93616324258, replyNumber=0, likeNumber=55, createdTime=2019-09-16, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b93616324258, moduleTitle=绿叶制药Rykindo有望成为我国在美获批上市的创新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b93616324258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632578, encodeId=bcd616325e8e1, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=类风湿性关节炎新药「塞妥珠单抗」在中国获批上市, objectType=article, longId=175608, objectId=f0901e560863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0901e560863, replyNumber=0, likeNumber=53, createdTime=2020-05-29, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0901e560863, moduleTitle=类风湿性关节炎新药「塞妥珠单抗」在中国获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0901e560863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632573, encodeId=f44516325e36d, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市, objectType=article, longId=163639, objectId=30a2163639f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30a2163639f7, replyNumber=0, likeNumber=92, createdTime=2019-10-10, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30a2163639f7, moduleTitle=诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30a2163639f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632576, encodeId=b8b916325e686, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=喜大普奔！拜耳治疗子宫内膜异位症新药唯散宁®获批上市, objectType=article, longId=166082, objectId=dd7016608221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd7016608221, replyNumber=0, likeNumber=67, createdTime=2020-03-20, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd7016608221, moduleTitle=喜大普奔！拜耳治疗子宫内膜异位症新药唯散宁®获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd7016608221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632564, encodeId=888c1632564ae, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=国产PD-1抗体获批上市，预期价格更“亲民”, objectType=article, longId=156099, objectId=d37115609944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d37115609944, replyNumber=0, likeNumber=73, createdTime=2019-04-26, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d37115609944, moduleTitle=国产PD-1抗体获批上市，预期价格更“亲民”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d37115609944)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632580, encodeId=a391163258094, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=首家通过一致性评价，广州白云山AD药物盐酸美金刚片获批上市, objectType=article, longId=179971, objectId=7a9a1e99712d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a9a1e99712d, replyNumber=0, likeNumber=63, createdTime=2019-10-11, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a9a1e99712d, moduleTitle=首家通过一致性评价，广州白云山AD药物盐酸美金刚片获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a9a1e99712d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632581, encodeId=621b16325819a, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=国家药监局批准我国首台自主知识产权碳离子治疗系统获批上市，应用于实体肿瘤治疗, objectType=article, longId=180346, objectId=7581180346f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7581180346f8, replyNumber=0, likeNumber=77, createdTime=2020-03-21, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7581180346f8, moduleTitle=国家药监局批准我国首台自主知识产权碳离子治疗系统获批上市，应用于实体肿瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7581180346f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632569, encodeId=d4121632569a1, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=国产生物类似药利妥昔单抗获批上市, objectType=article, longId=161099, objectId=2fe916109976, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fe916109976, replyNumber=0, likeNumber=91, createdTime=2019-12-24, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fe916109976, moduleTitle=国产生物类似药利妥昔单抗获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fe916109976)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632567, encodeId=36a1163256e51, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=迅速缓解口腔黏膜炎疼痛新型口腔凝胶益普舒获批上市, objectType=article, longId=160755, objectId=71df160e55c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71df160e55c8, replyNumber=0, likeNumber=69, createdTime=2019-05-15, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71df160e55c8, moduleTitle=迅速缓解口腔黏膜炎疼痛新型口腔凝胶益普舒获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71df160e55c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632565, encodeId=23ca1632565f3, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=荐读｜人体细胞中发现抗埃博拉病毒蛋白！治疗肾性贫血新药罗沙司他胶囊获批上市！, objectType=article, longId=156313, objectId=bb5f15631325, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb5f15631325, replyNumber=0, likeNumber=59, createdTime=2019-09-07, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb5f15631325, moduleTitle=荐读｜人体细胞中发现抗埃博拉病毒蛋白！治疗肾性贫血新药罗沙司他胶囊获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb5f15631325)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632577, encodeId=74dc16325e76b, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=银屑病治疗药物本维莫德乳膏获批上市, objectType=article, longId=167402, objectId=130e16e402bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=130e16e402bf, replyNumber=0, likeNumber=58, createdTime=2019-08-11, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=130e16e402bf, moduleTitle=银屑病治疗药物本维莫德乳膏获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=130e16e402bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632571, encodeId=092b16325e138, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=重磅！慢性阻塞性肺疾病吸入剂产品杰润®及希润®在中国获批上市, objectType=article, longId=162509, objectId=bbfd1625090b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbfd1625090b, replyNumber=0, likeNumber=71, createdTime=2019-07-01, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbfd1625090b, moduleTitle=重磅！慢性阻塞性肺疾病吸入剂产品杰润®及希润®在中国获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbfd1625090b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

获批上市

2020-05-29

weiz (审核中...)

前往app查看评论内容

#获批上市#

重量减轻10倍！全球**便携式MRI床头扫描仪获批上市

2020-09-10

weiz (审核中...)

前往app查看评论内容

#获批上市#

潜在治疗新冠肺炎药物获批上市，湖北以外新增确诊病例13连降

2020-06-09

weiz (审核中...)

前往app查看评论内容

#获批上市#

全球第二款！中国自主研发13价肺炎结合疫苗获批上市

2020-04-14

weiz (审核中...)

前往app查看评论内容

#获批上市#

国产重组人乳头瘤病毒疫苗“馨可宁”获批上市

2020-06-20

weiz (审核中...)

前往app查看评论内容

#获批上市#

百济神州抗PD-1抗体药物百泽安®（替雷利珠单抗注射液）终于获批上市了

2020-02-03

weiz (审核中...)

前往app查看评论内容

#获批上市#

罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症

2019-08-21

weiz (审核中...)

前往app查看评论内容

#获批上市#

中国首台自主知识产权碳离子治疗系统获批上市

2020-08-30

weiz (审核中...)

前往app查看评论内容

#获批上市#

全球用于稳定期慢阻肺治疗的一天一次三联吸入制剂“全再乐”在中国获批上市

2020-05-24

weiz (审核中...)

前往app查看评论内容

#获批上市#

绿叶制药Rykindo有望成为我国在美获批上市的创新药

2019-09-16

weiz (审核中...)

前往app查看评论内容

#获批上市#

类风湿性关节炎新药「塞妥珠单抗」在中国获批上市

2020-05-29

weiz (审核中...)

前往app查看评论内容

#获批上市#

诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市

2019-10-10

weiz (审核中...)

前往app查看评论内容

#获批上市#

喜大普奔！拜耳治疗子宫内膜异位症新药唯散宁®获批上市

2020-03-20

weiz (审核中...)

前往app查看评论内容

#获批上市#

国产PD-1抗体获批上市，预期价格更“亲民”

2019-04-26

weiz (审核中...)

前往app查看评论内容

#获批上市#

首家通过一致性评价，广州白云山AD药物盐酸美金刚片获批上市

2019-10-11

weiz (审核中...)

前往app查看评论内容

#获批上市#

国家药监局批准我国首台自主知识产权碳离子治疗系统获批上市，应用于实体肿瘤治疗

2020-03-21

weiz (审核中...)

前往app查看评论内容

#获批上市#

国产生物类似药利妥昔单抗获批上市

2019-12-24

weiz (审核中...)

前往app查看评论内容

#获批上市#

迅速缓解口腔黏膜炎疼痛新型口腔凝胶益普舒获批上市

2019-05-15

weiz (审核中...)

前往app查看评论内容

#获批上市#

荐读｜人体细胞中发现抗埃博拉病毒蛋白！治疗肾性贫血新药罗沙司他胶囊获批上市！

2019-09-07

weiz (审核中...)

前往app查看评论内容

#获批上市#

银屑病治疗药物本维莫德乳膏获批上市

2019-08-11

weiz (审核中...)

前往app查看评论内容

#获批上市#

重磅！慢性阻塞性肺疾病吸入剂产品杰润®及希润®在中国获批上市

2019-07-01

科室
- - 订阅+
  - 更多科室
工具
服务